Richard Weiner
Foot Surgery · Dallas, TXNPI 1578566238
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Stimwave Technologies Incorporated accounts for 70.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $9,738 and has fallen 98.2% since, to $172 in 2023.
Across 36 payments — averaging $309.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$8K
- Pylant Medical$1K
- Kerecis Limited$512
- Integra Lifesciences Corporation$258
- Smith+Nephew$231
- Wound Management Technologies, Inc$223
- plus $991 from 10 others
What the payments were for
- Consulting fees$4,00036%
- Travel & lodging$3,12528%
- Food & beverage$2,89126%
- Education$1,11510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stimwave Technologies Incorporated | 10 | $7,801 |
| Pylant Medical | 1 | $1,115 |
| Kerecis Limited | 3 | $512 |
| Integra Lifesciences Corporation | 1 | $258 |
| Smith+Nephew | 2 | $231 |
| Wound Management Technologies, Inc | 6 | $223 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $176 |
| Nevro Corp. | 2 | $159 |
| Paragon 28, Inc. | 1 | $145 |
| Orthofix Medical, Inc. | 2 | $136 |
| Melinta Therapeutics, LLC | 1 | $121 |
| Sanara Medtech Inc. | 1 | $110 |
| Medtronic | 1 | $79 |
| Bioventus LLC | 1 | $27 |
| Novum Pharma, LLC | 1 | $20 |
| Amgen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$688
- CYTAL$517
- Kerecis Omega3 GraftGuide$369
- Kerecis Omega3 Wound$352
- CellerateRx$221
- Kerecis Omega3 Surgibind$209
- Kerecis Omega3 Marigen$160
- Product Portfolio$145
- Omnia$138
- VERSAJET II$125
- Physio-Stim$123
- Baxdela$121
- DUOBRII$112
- REGRANEX$106
How this compares
$11,131 in reported general payments places this provider in the 80th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot surgery in Dallas
- Richard GalperinDallas$12K
- Jon NathansonDallas$2K
- Darlene CarterDallas$2K
- Ivan AshtonDallas$1K
- Roy AshtonDallas$707
- Scott AshtonDallas$381
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.